XML 42 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Cash Flows from Operating Activities:      
Net income (loss) $ 7,608 $ 12,469 $ (50,792)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 1,659 521 215
Loss on disposal of equipment 0 37 0
Stock-based compensation 2,169 1,323 767
Impairment of inventory 3,923 0 0
Deferred income tax benefit (892) (2,723) 0
Non-cash interest expense from convertible debentures 0 0 4,747
Non-cash interest expense from amortization of deferred offering costs 0 0 845
Change in fair value of derivative liabilities 0 6,741 48,454
Changes in operating assets and liabilities:      
Decrease/(increase) in accounts receivable and income tax receivable (3,653) 609 (540)
(Increase) in inventory (3,356) (9,228) (1,631)
(Increase) in prepaid expenses and deposits (1,065) (762) (334)
(Increase) in long-term deposits (1,168) (310) (4)
Increase in accounts payable 1,606 2,816 28
Increase/(decrease) in customer deposits (13) 120 (1)
Increase in accrued expenses 3,403 7,581 2,933
Increase/(decrease) in other long-term liabilities 441 195 (6)
Net Cash Provided by Operating Activities 10,662 19,389 4,681
Cash Flows from Investing Activities:      
Redemption of marketable securities 0 350 75
Purchase of equipment (5,080) (2,194) (122)
Purchase of intangible assets 0 (52) (42)
Net Cash Used in Investing Activities (5,080) (1,896) (89)
Cash Flows from Financing Activities:      
Net payments on revolving line of credit and accrued interest 0 (434) 0
Excess tax benefits from stock based compensation 1,406 388 0
Exercise of options and warrants 1,694 1,768 169
Repurchase of company stock (7,123) (976) 0
Net Cash (Used In) Provided by Financing Activities (4,023) 746 169
Foreign Currency Effect on cash 92 38 (28)
Increase in cash and cash equivalents 1,651 18,277 4,733
Cash and Cash Equivalents - beginning of period 24,648 6,371 1,638
Cash and Cash Equivalents - end of period 26,299 24,648 6,371
Non Cash Investing and Financing Activities:      
Conversion of debt to common stock 0 0 5,570
Conversion of derivative to common stock 0 0 26,749
Exercise of warrant liabilities 0 17,604 12,931
Increase in property and equipment/other long-term liabilities 359 0 0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION      
Cash paid for interest expense 3 0 385
Cash paid for income taxes 6,090 3,701 56
Common shares issued upon cashless warrant exercises (shares) 3,793 10,297 8,834
Total cashless exercise price of warrants $ 2,147 $ 5,995 $ 6,395
Gross warrants underlying cashless exercises (in shares) 4,564 12,563 12,930